MATINAS BIOPHARMA

MATINAS BIOPHARMA

MATINAS BIOPHARMA

Matinas (OTCQB: MTNB) is identifying & developing safe/effective antifungal & anti-bacterial therapeutics for treatment of serious & life-threatening infections
Founded
2011
Raised
$14.4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,400,000
Venture capital (Series A) - 2016
$10,000,000
Venture capital - 2015
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when MATINAS BIOPHARMA makes some noise.